NO146698C - Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt. - Google Patents
Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt.Info
- Publication number
- NO146698C NO146698C NO760118A NO760118A NO146698C NO 146698 C NO146698 C NO 146698C NO 760118 A NO760118 A NO 760118A NO 760118 A NO760118 A NO 760118A NO 146698 C NO146698 C NO 146698C
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- procedure
- stable long
- insulin product
- effective insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK8375AA DK140801B (da) | 1975-01-15 | 1975-01-15 | Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO760118L NO760118L (sv) | 1976-07-16 |
| NO146698B NO146698B (no) | 1982-08-16 |
| NO146698C true NO146698C (no) | 1982-11-24 |
Family
ID=8089535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO760118A NO146698C (no) | 1975-01-15 | 1976-01-14 | Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt. |
Country Status (36)
| Country | Link |
|---|---|
| JP (1) | JPS5946939B2 (sv) |
| AR (1) | AR213088A1 (sv) |
| AT (1) | AT362492B (sv) |
| BE (1) | BE837600A (sv) |
| BR (1) | BR7600206A (sv) |
| CA (1) | CA1094549A (sv) |
| CH (1) | CH631625A5 (sv) |
| CS (1) | CS208147B2 (sv) |
| DD (1) | DD124379A5 (sv) |
| DE (1) | DE2600971C2 (sv) |
| DK (1) | DK140801B (sv) |
| EG (1) | EG11988A (sv) |
| ES (1) | ES444558A1 (sv) |
| FI (1) | FI66751C (sv) |
| FR (1) | FR2297634A1 (sv) |
| GB (1) | GB1524431A (sv) |
| GR (1) | GR58608B (sv) |
| HU (1) | HU175142B (sv) |
| IE (1) | IE42395B1 (sv) |
| IL (1) | IL48845A (sv) |
| IN (1) | IN143279B (sv) |
| IT (1) | IT1054211B (sv) |
| KE (1) | KE2919A (sv) |
| LU (1) | LU74175A1 (sv) |
| MX (1) | MX4052E (sv) |
| MY (1) | MY7900169A (sv) |
| NL (1) | NL166464C (sv) |
| NO (1) | NO146698C (sv) |
| NZ (1) | NZ179733A (sv) |
| OA (1) | OA05209A (sv) |
| PL (1) | PL99927B1 (sv) |
| PT (1) | PT64696B (sv) |
| RO (1) | RO71576A (sv) |
| SE (1) | SE437219B (sv) |
| YU (1) | YU8376A (sv) |
| ZA (1) | ZA7658B (sv) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447728A (en) | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
| US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| US6051258A (en) | 1995-06-07 | 2000-04-18 | Emisphere Technologies, Inc. | Proteinoid emulsions and methods for preparation and use thereof |
| US6071538A (en) | 1992-06-15 | 2000-06-06 | Emisphere Technologies, Inc. | Oral delivery composition comprising supramolecular complex |
| US6100298A (en) | 1993-04-22 | 2000-08-08 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6100285A (en) | 1995-06-07 | 2000-08-08 | Emisphere Technologies, Inc. | Method of solubilizing itraconazole |
| US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK374579A (da) * | 1979-09-07 | 1981-03-08 | Nordisk Insulinlab | Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat |
| US4459226A (en) * | 1982-02-26 | 1984-07-10 | Eli Lilly And Company | Process for recovering insulin |
| US4801575A (en) * | 1986-07-30 | 1989-01-31 | The Regents Of The University Of California | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| AU609769B2 (en) * | 1987-02-10 | 1991-05-09 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of proteins |
| US4878892A (en) * | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| WO2010112358A2 (de) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | Verfahren zur beschichtung einer oberfläche eines bauteils |
| JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
| EA026241B1 (ru) | 2009-11-25 | 2017-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Распылитель |
| JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| JP5874724B2 (ja) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| US9744313B2 (en) | 2013-08-09 | 2017-08-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
| DK3139979T3 (da) | 2014-05-07 | 2023-10-09 | Boehringer Ingelheim Int | Enhed, forstøver og fremgangsmåde |
| NZ724449A (en) | 2014-05-07 | 2022-01-28 | Boehringer Ingelheim Int | Nebulizer and container |
| EP3139984B1 (en) | 2014-05-07 | 2021-04-28 | Boehringer Ingelheim International GmbH | Nebulizer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1285023A (en) * | 1968-08-09 | 1972-08-09 | Novo Terapeutisk Labor As | Improvements in or relating to injectable insulin preparations |
| US3758683A (en) * | 1971-04-30 | 1973-09-11 | R Jackson | Insulin product |
-
1975
- 1975-01-15 DK DK8375AA patent/DK140801B/da not_active IP Right Cessation
-
1976
- 1976-01-06 ZA ZA00760058A patent/ZA7658B/xx unknown
- 1976-01-07 IN IN41/CAL/76A patent/IN143279B/en unknown
- 1976-01-07 GR GR49734A patent/GR58608B/el unknown
- 1976-01-12 CA CA243,587A patent/CA1094549A/en not_active Expired
- 1976-01-12 FI FI760058A patent/FI66751C/fi not_active IP Right Cessation
- 1976-01-12 NZ NZ179733A patent/NZ179733A/xx unknown
- 1976-01-13 DE DE2600971A patent/DE2600971C2/de not_active Expired
- 1976-01-13 LU LU74175A patent/LU74175A1/xx unknown
- 1976-01-13 IE IE62/76A patent/IE42395B1/en unknown
- 1976-01-13 SE SE7600284A patent/SE437219B/sv not_active IP Right Cessation
- 1976-01-13 IT IT19221/76A patent/IT1054211B/it active
- 1976-01-14 DD DD190805A patent/DD124379A5/xx unknown
- 1976-01-14 RO RO7684491A patent/RO71576A/ro unknown
- 1976-01-14 PT PT64696A patent/PT64696B/pt unknown
- 1976-01-14 FR FR7600854A patent/FR2297634A1/fr active Granted
- 1976-01-14 AT AT21376A patent/AT362492B/de not_active IP Right Cessation
- 1976-01-14 BR BR7600206A patent/BR7600206A/pt unknown
- 1976-01-14 NO NO760118A patent/NO146698C/no unknown
- 1976-01-14 PL PL1976186526A patent/PL99927B1/pl unknown
- 1976-01-14 YU YU00083/76A patent/YU8376A/xx unknown
- 1976-01-14 GB GB1309/76A patent/GB1524431A/en not_active Expired
- 1976-01-14 NL NL7600338.A patent/NL166464C/xx not_active IP Right Cessation
- 1976-01-14 MX MX764822U patent/MX4052E/es unknown
- 1976-01-14 OA OA55703A patent/OA05209A/xx unknown
- 1976-01-15 CH CH47076A patent/CH631625A5/de not_active IP Right Cessation
- 1976-01-15 HU HU76NO198A patent/HU175142B/hu unknown
- 1976-01-15 ES ES444558A patent/ES444558A1/es not_active Expired
- 1976-01-15 CS CS76270A patent/CS208147B2/cs unknown
- 1976-01-15 IL IL48845A patent/IL48845A/xx unknown
- 1976-01-15 BE BE163542A patent/BE837600A/xx not_active IP Right Cessation
- 1976-01-16 JP JP51003293A patent/JPS5946939B2/ja not_active Expired
- 1976-01-17 EG EG16/76A patent/EG11988A/xx active
-
1978
- 1978-01-14 AR AR261924A patent/AR213088A1/es active
-
1979
- 1979-02-07 KE KE2919A patent/KE2919A/xx unknown
- 1979-12-30 MY MY169/79A patent/MY7900169A/xx unknown
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447728A (en) | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
| US6071538A (en) | 1992-06-15 | 2000-06-06 | Emisphere Technologies, Inc. | Oral delivery composition comprising supramolecular complex |
| US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
| US6245359B1 (en) | 1992-06-15 | 2001-06-12 | Emisphere Technologies, Inc. | Active agent transport systems |
| US6100298A (en) | 1993-04-22 | 2000-08-08 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| US5935601A (en) * | 1994-04-22 | 1999-08-10 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| US6051258A (en) | 1995-06-07 | 2000-04-18 | Emisphere Technologies, Inc. | Proteinoid emulsions and methods for preparation and use thereof |
| US6100285A (en) | 1995-06-07 | 2000-08-08 | Emisphere Technologies, Inc. | Method of solubilizing itraconazole |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO146698C (no) | Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt. | |
| NL7706051A (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat. | |
| SE429970B (sv) | Forfarande for framstellning av glukopyranosido-1,6-mannit | |
| NL7604005A (nl) | Infusieset. | |
| NL179975C (nl) | Werkwijze ter bereiding van een geneesmiddel. | |
| SE448790B (sv) | Forfarande for framstellning av ett dokument | |
| NL7700911A (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat. | |
| DK258775A (da) | Fremgangsmade til fremstilling af et teprodukt | |
| NO149897C (no) | Fremgangsmaate til fremstilling av et kreppet papir | |
| SE7611241L (sv) | Forfarande for framstellning av medicintablett | |
| NO137843C (no) | Fremgangsmaate for fremstilling av et dehydratisert, rehydratiserbart, bakteriologisk stabilt fleskesvorprodukt | |
| SE7704689L (sv) | Forfarande for framstellning av insulin | |
| NL7611528A (nl) | Nieuwe gesubstitueerde 4-aminopyrazolen, werk- wijzen ter bereiding daarvan en geneesmiddelen, die deze verbindingen bevatten. | |
| NO144282C (no) | T fremgangsmaate til fremstilling av et stabilt matvareproduk | |
| RO72551A (ro) | Procedeu de preparare a unor alchiltiouree | |
| NO146044C (no) | Fremgangsmaate for fremstilling av et farmasoeytisk insulin-preparat for rektal bruk | |
| NL7609532A (nl) | Druppelteller voor infuusinrichtingen. | |
| NL7613426A (nl) | Werkwijze ter bereiding van een geneesmiddel. | |
| SE435619C (sv) | Forfarande for framstellning av en 6alfa-deoxitetracyklin | |
| RO69885A (ro) | Procedeu de preparare a l-piroglutamil-l-prolinamidei | |
| NO148332C (no) | Fremgangsmaate ved fremstilling av et peptid. | |
| SE7705851L (sv) | Forfarande for framstellning av en farmaceutisk komposition | |
| NO145125C (no) | Fremgangsmaate for fremstilling av et osteprodukt. | |
| CS189001B2 (en) | Process for preparing optically active 13,14-dehydro-11-deoxyprostaglandines | |
| NO822985L (no) | Fremgangsmaate for fremstilling av et insulinpreparat. |